To gain insight into the mechanism by which hsa-miR-3937 operates as an oncogenic miRNA in CRC cells, we used TargetScan to estimate the binding location of hsa-miR-3937 on the target gene BCL2L12. Here, BCL2L12 is linked to colorectal carcinoma.